SOBRsafe and Orbiit Announce Partnership to Enhance Alcohol Recovery Through AI and Wearable Technology
SOBRsafe (NASDAQ:SOBR) and Orbiit have announced a strategic AI partnership to enhance alcohol recovery solutions. The collaboration combines SOBRsafe's transdermal alcohol detection wristband with Orbiit's AI-powered engagement platform to provide comprehensive support for individuals managing sobriety.
The partnership addresses a significant market need, as over 28 million Americans suffered from Alcohol Use Disorder (AUD) in 2023, with only 15.6% receiving treatment. The solution integrates three key components: the SOBRsure Band for continuous alcohol detection, AI-Powered Orbie for 24/7 support, and SMS accountability messaging.
The Orbiit Recovery Program is priced at $3,995 for a six-month program, including the SOBRsure band and full access to Orbiit's AI platform. The program combines wearable technology with behavioral science principles to enhance accountability, motivation, and long-term recovery success.
SOBRsafe (NASDAQ:SOBR) e Orbiit hanno annunciato una partnership strategica nel settore dell'IA per migliorare le soluzioni di recupero dall'alcol. La collaborazione combina il braccialetto per la rilevazione transdermica dell'alcol di SOBRsafe con la piattaforma di coinvolgimento alimentata dall'IA di Orbiit per fornire un supporto completo a chi gestisce la sobrietà.
La partnership risponde a un'importante esigenza di mercato, poiché oltre 28 milioni di americani hanno sofferto di Disturbo da Uso di Alcol (AUD) nel 2023, con solo il 15,6% che riceve trattamenti. La soluzione integra tre componenti chiave: il SOBRsure Band per la rilevazione continua dell'alcol, l'Orbie alimentato dall'IA per supporto 24 ore su 24, e messaggi di responsabilità via SMS.
Il Programma di Recupero Orbiit ha un costo di $3,995 per un programma di sei mesi, comprensivo del braccialetto SOBRsure e accesso completo alla piattaforma IA di Orbiit. Il programma combina tecnologia indossabile con principi di scienza comportamentale per migliorare responsabilità, motivazione e successo del recupero a lungo termine.
SOBRsafe (NASDAQ:SOBR) y Orbiit han anunciado una asociación estratégica en IA para mejorar las soluciones de recuperación de alcohol. La colaboración combina la pulsera de detección transdérmica de alcohol de SOBRsafe con la plataforma de compromiso impulsada por IA de Orbiit para proporcionar un apoyo integral a las personas que gestionan la sobriedad.
La asociación aborda una necesidad significativa del mercado, ya que más de 28 millones de estadounidenses sufrieron de Trastorno por Uso de Alcohol (AUD) en 2023, con solo el 15.6% recibiendo tratamiento. La solución integra tres componentes clave: la SOBRsure Band para la detección continua de alcohol, Orbie impulsado por IA para apoyo 24/7 y mensajes de responsabilidad por SMS.
El Programa de Recuperación Orbiit tiene un precio de $3,995 por un programa de seis meses, que incluye la pulsera SOBRsure y acceso completo a la plataforma de IA de Orbiit. El programa combina tecnología portátil con principios de ciencia del comportamiento para mejorar la responsabilidad, la motivación y el éxito en la recuperación a largo plazo.
SOBRsafe (NASDAQ:SOBR)와 Orbiit은 알코올 회복 솔루션을 강화하기 위한 전략적 AI 파트너십을 발표했습니다. 이 협업은 SOBRsafe의 피부를 통한 알코올 감지 팔찌와 Orbiit의 AI 기반 참여 플랫폼을 결합하여 절주를 관리하는 개인에게 포괄적인 지원을 제공합니다.
이 파트너십은 2023년 2800만 명 이상의 미국인이 알코올 사용 장애(AUD)로 고통받았으며, 단 15.6%만 치료를 받았다는 중요한 시장의 필요를 해결합니다. 이 솔루션은 세 가지 주요 구성 요소를 통합합니다: 지속적인 알코올 감지를 위한 SOBRsure Band, 24시간 지원을 위한 AI 기반 Orbie, 그리고 SMS 책임 메시징입니다.
Orbiit 회복 프로그램은 SOBRsure 밴드와 Orbiit의 AI 플랫폼에 대한 전체 접근을 포함하여 6개월 프로그램에 대해 $3,995의 가격이 책정되어 있습니다. 이 프로그램은 웨어러블 기술과 행동 과학 원칙을 결합하여 책임감, 동기 부여 및 장기 회복 성공을 향상시킵니다.
SOBRsafe (NASDAQ:SOBR) et Orbiit ont annoncé un partenariat stratégique en IA pour améliorer les solutions de rétablissement liées à l'alcool. Cette collaboration combine le bracelet de détection d'alcool transdermique de SOBRsafe avec la plateforme d'engagement alimentée par l'IA d'Orbiit pour fournir un soutien complet aux personnes gérant leur sobriété.
Ce partenariat répond à un besoin de marché significatif, puisque plus de 28 millions d'Américains ont souffert de trouble lié à l'usage de l'alcool (AUD) en 2023, dont seulement 15,6 % ont reçu un traitement. La solution intègre trois composants clés : le SOBRsure Band pour la détection continue de l'alcool, Orbie alimenté par l'IA pour un soutien 24/7, et des messages de responsabilité par SMS.
Le Programme de Récupération Orbiit est proposé au prix de 3 995 $ pour un programme de six mois, incluant le bracelet SOBRsure et un accès complet à la plateforme IA d'Orbiit. Ce programme combine technologie portable et principes de sciences comportementales pour améliorer la responsabilité, la motivation et le succès à long terme du rétablissement.
SOBRsafe (NASDAQ:SOBR) und Orbiit haben eine strategische KI-Partnerschaft angekündigt, um Lösungen zur Alkoholrehabilitation zu verbessern. Die Zusammenarbeit kombiniert das transdermale Alkohol-Detektionsarmband von SOBRsafe mit der KI-gestützten Engagement-Plattform von Orbiit, um umfassende Unterstützung für Personen zu bieten, die ihre Abstinenz verwalten.
Die Partnerschaft reagiert auf einen signifikanten Marktbedarf, da über 28 Millionen Amerikaner im Jahr 2023 an Alkoholgebrauchsstörung (AUD) litten, von denen nur 15,6% eine Behandlung erhielten. Die Lösung integriert drei Schlüsselkomponenten: das SOBRsure Band für die kontinuierliche Alkoholüberwachung, den KI-gestützten Orbie für 24/7-Unterstützung und SMS-Verantwortlichkeitsnachrichten.
Das Orbiit-Rehabilitationsprogramm kostet 3.995 $ für ein sechsmonatiges Programm, das das SOBRsure-Band und den vollständigen Zugang zur KI-Plattform von Orbiit umfasst. Das Programm kombiniert tragbare Technologie mit Prinzipien der Verhaltenswissenschaft, um Verantwortung, Motivation und langfristigen Erfolg bei der Genesung zu fördern.
- Launch of new revenue stream through $3,995 six-month recovery program
- Strategic partnership expanding market reach in alcohol recovery sector
- Integration of AI technology enhancing product offering
- Large addressable market with 28 million potential users in the US
- None.
Insights
This strategic partnership represents a significant pivot for SOBRsafe, moving beyond hardware into the lucrative digital health solutions market. The $3,995 price point for the six-month program positions the offering in the premium segment of the recovery support market, potentially generating substantial recurring revenue if successful adoption is achieved.
The market opportunity is compelling: with 28 million Americans affected by AUD and only 15.6% receiving treatment, capturing even a small percentage of this untapped market could translate into meaningful revenue growth. At the current price point, securing just 1,000 program participants would generate nearly
The integration of SOBRsafe's hardware with Orbiit's AI platform creates several competitive advantages:
- Continuous monitoring through transdermal technology provides objective data collection
- 24/7 AI support addresses the critical gap in traditional recovery programs
- The combination of physical wearable and digital support creates higher switching costs, potentially improving customer retention
However, key considerations for investors include:
- Customer acquisition costs in the behavioral health space typically run high
- Insurance reimbursement status remains unclear, which could impact adoption rates
- The premium pricing strategy may limit market penetration in price-sensitive segments
The partnership also opens possibilities for future revenue streams through data analytics and potential integration with healthcare providers' systems. The endorsement from Emory University's neuroscientist adds credibility to the solution's scientific foundation, potentially facilitating broader institutional adoption.
According to AmericanAddictionCenters.org, over 28 million people in the
"We are inspired to partner with Orbiit on our shared mission to introduce innovative solutions to individuals on their sobriety journey," said David Gandini, CEO of SOBRsafe. "In addition to the continuous transdermal alcohol detection, real-time alerts and GPS tracking we already offer with our discrete SOBRsure band, SOBRsure users who engage with Orbiit's platform will now have access to 24/7 AI support."
"Human behavior is deeply shaped by habit formation and social reinforcement," said Dr. Edward Valentin, Ph.D, LCSW MAC, a staff neuroscientist at Emory University and research and development consultant for Orbiit. "Integrating wearables like the SOBRsure band with real-time monitoring with Orbiit's daily interventions aligns with well-established behavioral science and affective neuroscience principles. By leveraging classical conditioning and cognitive reinforcement, this partnership has the potential to enhance accountability, motivation and long-term recovery success."
The new partnership features three key components:
- SOBRsure™ Band – SOBRsafe's wearable device provides passive, transdermal (touch-based) alcohol detection and serves as a constant, visual reminder of an individual's sobriety commitment
- AI-Powered Orbie – A sophisticated chatbot and support system that offers 24/7 engagement, personalized interventions and structured micro-courses designed to reinforce recovery habits
- SMS Accountability Messaging – Strategically timed messages every day keep users engaged, providing encouragement and actionable insights while seamlessly integrating into daily life
The Orbiit Recovery Program is a six-month initiative priced at
By merging AI and wearable technology, SOBRsafe and Orbiit are setting a new standard for alcohol recovery solutions. For more information about the companies and program availability, please visit https://myorbiit.com and https://sobrsafe.com.
1Source: American Addiction Centers
ABOUT SOBRsafe
Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic and unconnected. There has to be a better way.
Enter SOBRsafe™. Our advanced transdermal (touch-based) technology detects and instantaneously reports the presence of alcohol as emitted through a user's skin - no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for the behavioral health, judicial and consumer markets, and for licensing and integration.
The SOBRsafe technology is commercially available for point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure). At SOBRsafe, we are creating a culture of prevention and support. To learn more, visit www.sobrsafe.com.
ABOUT Orbiit
Welcome to Orbiit, where innovation and compassion intersect to transform the landscape of addiction recovery. Our journey began with a simple yet powerful vision: to create a recovery program that not only addresses the complexities of addiction but also harnesses the power of cutting-edge technology to provide continuous, personalized support. Orbiit is a dynamic program that can be used as an after plan, probation fulfillment, accountability strategy and of course as a first line recovery guide.
PRESS CONTACT
Talia Rotenberg
talia@stanton-company.com
310.339.3591
Safe Harbor Statement
Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. The Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing Sections. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sobrsafe-and-orbiit-announce-partnership-to-enhance-alcohol-recovery-through-ai-and-wearable-technology-302380958.html
SOURCE SOBR Safe, Inc.
FAQ
What is the cost of SOBRsafe and Orbiit's new recovery program?
What are the key components of SOBRsafe's partnership with Orbiit?
How many people could benefit from SOBR's alcohol recovery solution?
What technology does the SOBRsure band use to detect alcohol?
How does SOBR's partnership with Orbiit enhance recovery support?
